213 results on '"Gaikwad, Amos"'
Search Results
2. Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation
3. Amphiregulin Exerts Proangiogenic Effects in Developing Murine Lungs
4. Improving diagnosis and treatment of acute childhood leukemia in Uganda: impact of flow cytometry
5. Effects of the Tumor Inhibitory Triterpenoid Avicin G on Cell Integrity, Cytokinesis, and Protein Ubiquitination in Fission Yeast
6. Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance
7. CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia
8. A 43 kDa DNA binding protein from the pea chloroplast interacts with and stimulates the cognate DNA polymerase.
9. High Preponderance of High-Risk Phenotypes of Acute Leukemias Among Ugandan Children
10. Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression
11. Functional Analysis of Pea Chloroplast DNA Polymerase and its Accessory Proteins
12. Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma
13. Short NK- and Naïve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study
14. Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression.
15. Avicin D Selectively Induces Apoptosis and Downregulates p-STAT-3, bcl-2, and Survivin in Cutaneous T-Cell Lymphoma Cells
16. Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor
17. Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome
18. Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera
19. Imatinib effect on growth and signal transduction in polycythemia vera
20. In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele
21. Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series
22. Strategies to Improve Pediatric Cancer Pathology and Tissue Handling for Clinical Care and Research in Low-Resource Settings
23. Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia
24. Short NK- and Naïve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.
25. The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation
26. Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery
27. Brown adipose tissue mitochondria are cytochrome c — subsaturated
28. Suppression of pea nuclear topoisomerase I enzyme activity by pea PCNA
29. Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia
30. A clinicopathologic study of the spectrum of systemic forms of EBV‐associated T‐cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America
31. Disruption of Dihydronicotinamide Riboside:Quinone Oxidoreductase 2 (NQO2) Leads to Myeloid Hyperplasia of Bone Marrow and Decreased Sensitivity to Menadione Toxicity
32. In Vivo Role of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) in the Regulation of Intracellular Redox State and Accumulation of Abdominal Adipose Tissue
33. Retraction: Disruption of the NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Gene in Mice Causes Myelogenous Hyperplasia
34. Polycythemia vera is not initiated by JAK2 V617F mutation
35. Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1:6)(q25;p23) After Treatment for High-risk Neuroblastoma
36. Aberrant Precursor B Lymphoid Blast Population in a Patient with Juvenile Myelomonocytic Leukemia
37. Differential Expression of Adhesion Molecule Receptors May Influence Bone Marrow Microenvironment-Mediated Protection of Leukemia-Initiating Cells (LICs) in Infant MLL-rearranged (MLL-R) Acute Lymphoblastic Leukemia (ALL)
38. Clonal, Exhausted and Activated Infiltrating T Lymphocytes in Langerhans Cell Histiocytosis Lesions
39. Comparision of four and six color multiparametric flow cytometry panels to diagnose pediatric leukemias
40. Donor Derived Myelodysplastic Syndrome in a Pediatric Allogeneic Transplant Recipient
41. Immune Checkpoint Inhibitors Restore Function of Lesion Infiltrating T Lymphocytes in Langerhans Cell Histiocytosis
42. Detection of Lymphoid and Myeloid Lineages in Infantile B Acute Lymphoblastic Leukemia With Mixed Lineage Leukemia Rearrangement by Use of Flow Cytometry and Cytogenetics
43. Detection of Lymphoid and Myeloid Lineages in Infantile B-Cell Acute Lymphoblastic Leukemia With Mixed-Lineage Leukemia Rearrangement by Use of Flow Cytometry and Cytogenetic Analysis
44. Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans Cells
45. Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor
46. Characterization of the Putative Stem Cells From Umbilical Cord Blood.
47. Prevalence and clinical correlates ofJAK2mutations in Down syndrome acute lymphoblastic leukaemia
48. Gene Expression Profiling Differentiates Childhood Acute Lymphoblastic Leukemia in Down Syndrome Versus Non-Down Syndrome Patients.
49. Prevalence and Clinical Correlates of JAK2 Mutations in Pediatric Down Syndrome Acute Lymphoblastic Leukemia.
50. Bone Marrow Stromal Cells Reverse Proapoptotic Effects of JAK2 Inhibitor Atiprimod in Cells Carrying the JAK2V617F mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.